Poorer outcomes in epithelial ovarian cancer were correlated with enhanced levels of leptin, as well as the expression of its receptor and the leptin to adiponectin ratio (Kato et al., 2015; Diaz et al., 2013). Here, ADIPOQ is linked to ovarian carcinoma.